JPS5738785A - 3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same - Google Patents

3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same

Info

Publication number
JPS5738785A
JPS5738785A JP10076481A JP10076481A JPS5738785A JP S5738785 A JPS5738785 A JP S5738785A JP 10076481 A JP10076481 A JP 10076481A JP 10076481 A JP10076481 A JP 10076481A JP S5738785 A JPS5738785 A JP S5738785A
Authority
JP
Japan
Prior art keywords
thiomethylcephalosporin
triazinyl
hydroxy
manufacture
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10076481A
Other languages
English (en)
Japanese (ja)
Inventor
Rabiyuu Berunaaru
Saari Ari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JPS5738785A publication Critical patent/JPS5738785A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10076481A 1980-06-30 1981-06-30 3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same Pending JPS5738785A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8014512A FR2485540A1 (fr) 1980-06-30 1980-06-30 Nouveaux derives antibiotiques des cephalosporines, leur procede de preparation et les medicaments en contenant

Publications (1)

Publication Number Publication Date
JPS5738785A true JPS5738785A (en) 1982-03-03

Family

ID=9243670

Family Applications (2)

Application Number Title Priority Date Filing Date
JP10076481A Pending JPS5738785A (en) 1980-06-30 1981-06-30 3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same
JP10076581A Pending JPS5738786A (en) 1980-06-30 1981-06-30 Cephalosporin sulfoxide derivative, manufacture and drug composition containing it

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP10076581A Pending JPS5738786A (en) 1980-06-30 1981-06-30 Cephalosporin sulfoxide derivative, manufacture and drug composition containing it

Country Status (4)

Country Link
JP (2) JPS5738785A (enrdf_load_stackoverflow)
AU (1) AU7241081A (enrdf_load_stackoverflow)
FR (1) FR2485540A1 (enrdf_load_stackoverflow)
ZA (2) ZA814394B (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367228A (en) * 1980-10-29 1983-01-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compound and composition
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
FR2546520B1 (fr) * 1983-05-27 1985-08-30 Sanofi Sa Nouveaux composes antibiotiques derives des cephalosporines
EP1660506A4 (en) * 2003-08-25 2009-02-25 Revaax Pharmaceuticals Llc ORAL NEUROTHERAPEUTIC CEFAZOLINE COMPOSITIONS

Also Published As

Publication number Publication date
FR2485540A1 (fr) 1981-12-31
ZA814392B (en) 1982-07-28
JPS5738786A (en) 1982-03-03
ZA814394B (en) 1982-09-29
AU7241081A (en) 1982-01-07
FR2485540B1 (enrdf_load_stackoverflow) 1984-02-24

Similar Documents

Publication Publication Date Title
PH17516A (en) Substituted iminodiacids,their preparation and pharmaceutical composition containing them
JPS57102878A (en) Novel 4,5-polymethylene-4-isothiazoline-3-one compound, manufacture and bactericide, medicine and cosmetic composition containing same
JPS5753473A (en) Novel n-aryl-2-oxazolidinones, manufacture and drug containing them
IL61930A (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it
JPS5731689A (en) Substituted benzamide, manufacture and medicinal composition containing same
IL63368A0 (en) 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them
IL58478A0 (en) Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines
PH16982A (en) Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide and its pharmaceutical composition
IL62660A (en) 4,5-diaryl-alpha(polyfluoroalkyl)-1h-pyrrole-2-methanamines,their preparation and pharmaceutical compositions containing them
IL64563A0 (en) 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them
IL64252A (en) 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them
IL64416A (en) N-cyclopropyloxyphenyl-n'-benzoylurea derivatives,process for the preparation thereof and insecticidal compositions containing them
IL63145A (en) Imidazothienopyrimidinedione derivatives,their manufacture and pharmaceutical compositions containing them
IL62167A0 (en) Phenoxy-aminopropanol derivatives,their manufacture and pharmaceutical compositions containing them
JPS57122084A (en) Substituted benzamide, manufacture and pharmaceutical composition containing same
JPS5724365A (en) Antitumoral compound, manufacture and medicinal composition containing same
JPS5750990A (en) Condensed as-triazine derivative, manufacture and medicinal composition containing same
JPS5738785A (en) 3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same
JPS5781493A (en) Ammoniomethyl compound, manufacture and medicinal composition containing same
PH16754A (en) Novel acylamino-benzazole derivatives,and pharmaceutical composition containing same
IL62592A0 (en) Phenyl-quinolizidines,their manufacture and pharmaceutical compositions containing them
IL63595A0 (en) Diaryl-imidazole compounds,their manufacture and pharmaceutical compositions containing them
IL63917A0 (en) 2-aminoimidazoles,their manufacture and pharmaceutical compositions containing them
JPS56127340A (en) Novel encephaline homologue, manufacture and medicinal composition
IL63572A0 (en) Polyazaheterocyclic compounds,their manufacture and pharmaceutical compositions containing them